Cleerly
Cleerly utilizes FDA-cleared, AI-powered solutions for advanced cardiovascular imaging, enabling comprehensive phenotyping of coronary artery disease. Its non-invasive CT imaging technology improves patient outcomes and aims to create a new standard of care for heart disease. The company's approach is grounded in scientific research based on millions of medical images.
Buy Funded Startups lists
Funding Round: Series C+
Funding Amount: $106M
Date: 04-Dec-2024
Investors: Insight Partners, Battery Ventures
Markets: Healthtech, AI, Medical Imaging, Cardiology, Digital Healthcare, Personalized Health, Heart Disease, AI Technology, Machine Learning, Cardiovascular AI Software
HQ: Denver, Colorado, United States
Founded: 2017
Website: https://cleerlyhealth.com/
LinkedIn: https://www.linkedin.com/company/cleerlyhealth
Twitter: https://twitter.com/Cleerlyhealth
Facebook: https://www.facebook.com/cleerlyhealth
Crunchbase: https://www.crunchbase.com/organization/cleerly
Leave a Comment
Comments
No comments yet.